Market Notice
Due to a current BidOnly situation the acquisition of this product is only possible under restrictions via stock exchange.
Agios Pharmaceuticals Inc./Faktor/Long [3]/MS
- BID
10.3
- ASK
-
- 400 Units0 Units
- 07/21, 19:30:53 PM
Product class
Factor with KO - Factor Warrant - with KO with Leverage
Last exchange day
Open End
Performance (1M)
48.57%
Basis price
26.7127 [USD]
Knock-Out barrier
26.7127 [USD]
Leverage
2.90
Multiplier
1.0587
Distance to KO barrier absolute
11.10 USD
Distance to KO barrier in %
29.35 %
Agio p.a. in %
-
Factor
3.00
Ø Tradable bid size main / secondary
0/0
Ø Tradable ask size main / secondary
0/0
Spread main / secondary
0.00/0.00
Tax presence main / secondary
-/-
Trade further knock-out products for Agios Pharmaceuticals, Inc. without exchange fees.
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 9.32 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 05:33:58 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 12.46 | 7.93 |
| PREV. DAY'S PRICE | 12.48 | (07/20) |
| CHANGE DAY BEFORE | -3.16 | -25.32 % |
| 52 WEEK HIGH / LOW | (-) | (-) |
Indicators
| TIME OF CALCULATION | 19:31:40 PM (07/21/2026) |
| AGIO P.A. IN % | - |
| LEVERAGE | 2.90 |
| DISTANCE TO KNOCK-OUT BARRIER ABSOLUTE | 11.10 USD |
| DISTANCE TO KNOCK-OUT BARRIER IN % | 29.35 % |
Master Data
| WKN | MM98N8 |
| ISIN | DE000MM98N81 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Leverage Product |
| PRODUCT CLASS | Factor with KO - Factor Warrant - with KO with Leverage |
| PRODUCT NAME | Faktor 3x Long Agios Pharmaceuticals emittiert von Morgan Stanley & Co. Int. plc |
| ISSUER | Morgan Stanley & Co. International plc |
| TRADING SEGMENT | EASY EUWAX |
| OPTION TYPE | call |
| UNDERLYING | AGIOS PHARMACEUTICALS INC USD0.001 |
| BASIS PRICE | 26.7127 [USD] |
| KNOCKOUT BARRIER | 26.7127 [USD] |
| KNOCKIN LEVEL | - [-] |
| FACTOR | 3.00 |
| RANGE | - - - |
| MULTIPLIER | 1.0587 |
| EXERCISE TYPE | American |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | EUR |
| SETTLEMENT CURRENCY | Euro |
| SMALLEST TRADABLE UNIT | 1.00 |
| MINIMUM QUOTATION EUR | 10,000.00 |
| MINIMUM QUOTATION UNITS | 10,000.00 |
| LAST VALUATION DAY | Open End |
| PAYMENT DATE | - |
| FIRST EXCHANGE DAY | 10/12/2025 |
| LAST EXCHANGE DAY | Open End |
| TRADING HOURS | 08:00:00 AM - 10:00:00 PM |
| QUOTATION | fortlaufende Auktion |
| ISSUE VOLUME | 405,000 |
| ROLLING | No |
| QUANTO | No |
Underlying
| WKN | A1W2RM |
| ISIN | US00847X1046 |
| SYMBOL | 8AP |
| NOMINAL CURRENCY | Euro |
| TYPE OF UNDERLYING | Equity |
| COUNTRY OF THE HOME STOCK EXCHANGE | Germany |
Issuer
| NAME | Morgan Stanley & Co. International plc |
| ADDRESS | Morgan Stanley & Co. International plc
25 Cabot Square, Canary Wharf
E14 4QA London
Großbritannien |
| EMAIL ADDRESS | strukturierte-produkte@morganstanley.com |
| SERVICE PHONE NUMBER | 069 21661234 |
| URL | https://zertifikate.morganstanley.com/ |
| DOCUMENTS | PRIIP / KID (english) |
| ISSUER PORTRAIT | PDF |
Product Description
This factor warrant provides the investor with a constant leverage of 3.00 to participate in the positive and negative performance of the Agios Pharmaceuticals Inc., which is the underlying instrument. This product has an unlimited term. The issuer has the right to terminate the warrant, subject to a specific notice period.